Pancreatic Cancer Research

ResearcherNational Institutes for Quantum Science and TechnologyActive in the last 2 years

Sumitaka Hasegawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7793-9759; OpenAlex author ID A5077274316. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Prognostic Significance of Plasma Soluble IL-6 Receptor in Carbon-ion Radiotherapy for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.17406↗
  2. Radiation-Induced Autophagy in Human Pancreatic Cancer Cells is Critically Dependent on G2 Checkpoint Activation: A Mechanism of Radioresistance in Pancreatic … Last author DOI 10.1016/j.ijrobp.2021.04.001↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tsuguhide Takeshima · 1 shared paper, 2025 · strength 0.28
  2. Tetsuro Isozaki · 1 shared paper, 2025 · strength 0.28
  3. Takashi Imai · 1 shared paper, 2025 · strength 0.28
  4. Makoto Shinoto · 1 shared paper, 2025 · strength 0.28
  5. Kazutaka Doi · 1 shared paper, 2025 · strength 0.28
  6. Motofumi Suzuki · 1 shared paper, 2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.